Acute‐on‐chronic liver failure (ACLF) is a frequent cause of death in cirrhosis. Albumin
dialysis with the molecular adsorbent recirculating system (MARS) decreases retained …

Objective: The hepatic integration of human adipose tissue derived mesenchymal stem cells
(hAT-MSCs) in vivo with or without prior differentiation to hepatocyte-like cells in vitro was …

Background Gemcitabine plus a platinum-based agent (eg, cisplatin or oxaliplatin) is the
standard of care for advanced biliary cancers. We investigated the addition of cetuximab to …

Aims: At present, clinical success of hepatocyte transplantation as an alternative to whole
liver transplantation is hampered by the limited availability of suitable donor organs for the …

Background/Aims Patients with cirrhosis are classified in a compensated and a decompensated
stage. Portal hypertension is responsible for most of the complications of cirrhosis that …

Background & Aims Patients with cirrhosis and variceal hemorrhage have a high risk of
rebleeding. We performed a prospective randomized trial to compare the prevention of …

Mesenchymal tissues harbour stromal cells capable of multilineage differentiation. Here, we
demonstrate the isolation of mesenchymal stem cells (MSC) from rat peritoneal adipose …

BACKGROUND COVID-19 convalescent plasma (CCP) has been considered a treatment
option for COVID-19. This trial assessed the efficacy of a neutralizing antibody containing high-…

Donor organ shortage is still the major obstacle for the clinical application of hepatocyte
transplantation in the treatment of liver diseases. However, generation of hepatocyte-like cells …

Background & Aims No established therapies for patients with hepatocellular carcinoma (HCC)
and progression on first-line sorafenib treatment currently exist. This phase I/II trial …